Letter to the Editor: Pointing the finger in the wrong direction on prescription drug prices

UTC
US NEWS FEEDS > WASHINGTON >

Matt Degooyer’s recent op-ed, “Addressing barriers to accessing biosimilars could help save Washington’s most vulnerable patients,” presents a misleading view regarding which parties in the prescription drug delivery system are responsible for the higher prices. Contrary to Matt Degooyer’s claims in his recent piece, pharmacy benefit managers (PBMs) fully support increasing the use of biosimilars to lower prescription
...
News Feed:
Washington State Wire

READ MORE >
Letter to the Editor: Pointing the finger in the wrong direction on prescription drug prices

Sponsored Content